Thus, pharmacologic doses of aspirin that give low mM serum concentrations can be accompanied by >30-fold higher concentrations of salicylate which are more than sufficient to inhibit colon cancer cell growth and decrease Sp1, Sp3, Sp4 and Sp-regulated genes (Fig. 3). The gene discussed is TFF2; the disease is malignant colon neoplasm.